Rapidly mainstreaming breakthrough medical research, sometimes called "bench to bedside," has become a bipartisan priority. The rapid development and dissemination of COVID-19 vaccines established a new focus on how lives can be saved and improved if regulatory pathways, research resources, and the medical professional acceptance were better aligned.
Dr. Tara Schwetz, a senior member of the President's Office of Science and Technology, is driving the establishment of the new Advanced Research Projects Agency for Health (ARPA-H). Legislation to establish and fund ARPA-H is now moving through Congress."
